B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-01
DOI
10.3389/fimmu.2020.602868
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
- (2020) Manit Munshi et al. Blood Cancer Journal
- How I treat Waldenström's Macroglobulinemia
- (2019) Meletios A Dimopoulos et al. BLOOD
- Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment
- (2019) Ryan M. Young et al. IMMUNOLOGICAL REVIEWS
- Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström’s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance
- (2019) Ayako Nakamura et al. PLoS One
- MYD88L265P Mutation in Lymphoid Malignancies
- (2018) Xinfang Yu et al. CANCER RESEARCH
- A multiprotein supercomplex controlling oncogenic signalling in lymphoma
- (2018) James D. Phelan et al. NATURE
- Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
- (2018) Robert A. Kyle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia
- (2018) Alessandra Tedeschi et al. HEMATOLOGICAL ONCOLOGY
- Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management
- (2018) Morie A. Gertz AMERICAN JOURNAL OF HEMATOLOGY
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma
- (2018) Kerstin Wenzl et al. Blood Cancer Journal
- Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
- (2017) Marzia Varettoni et al. HAEMATOLOGICA
- Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis
- (2017) Ju-Han Lee et al. Scientific Reports
- Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
- (2017) Marzia Varettoni et al. HAEMATOLOGICA
- Diagnosis and Management of Waldenström Macroglobulinemia
- (2017) Prashant Kapoor et al. JAMA Oncology
- B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice
- (2016) G. Knittel et al. BLOOD
- Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia
- (2016) Zachary R. Hunter et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia
- (2016) Jorge J. Castillo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
- (2016) Jean-Philippe Pradère et al. Science Signaling
- Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
- (2016) Jean-Philippe Pradère et al. Science Signaling
- The cellular origin and malignant transformation of Waldenstrom macroglobulinemia
- (2015) B. Paiva et al. BLOOD
- Clonal architecture ofCXCR4WHIM-like mutations in Waldenström Macroglobulinaemia
- (2015) Lian Xu et al. BRITISH JOURNAL OF HAEMATOLOGY
- MYD88L265P andCXCR4mutations in lymphoplasmacytic lymphoma identify cases with high disease activity
- (2015) Janine Schmidt et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genomic Landscape of CXCR4 Mutations in Waldenstro m Macroglobulinemia
- (2015) S. Poulain et al. CLINICAL CANCER RESEARCH
- The B-cell antigen receptor integrates adaptive and innate immune signals
- (2015) Kevin L. Otipoby et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma
- (2014) A. M. Roccaro et al. BLOOD
- Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia
- (2014) S. P. Treon et al. BLOOD
- Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization
- (2014) M. Avbelj et al. BLOOD
- Consequences of the recurrentMYD88L265Psomatic mutation for B cell tolerance
- (2014) James Q. Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Detection of MYD88 L265P in peripheral blood of patients with Waldenström’s Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance
- (2014) L Xu et al. LEUKEMIA
- Outcome Disparities among Ethnic Subgroups of Waldenström's Macroglobulinemia: A Population-Based Study
- (2014) Sikander Ailawadhi et al. ONCOLOGY
- A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia
- (2013) G. Yang et al. BLOOD
- MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance
- (2013) M. Varettoni et al. BLOOD
- MYD88 L265P mutation in Waldenstrom macroglobulinemia
- (2013) S. Poulain et al. BLOOD
- Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
- (2013) M. Varettoni et al. BLOOD
- The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
- (2013) Z. R. Hunter et al. BLOOD
- MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
- (2013) L. Xu et al. BLOOD
- MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia
- (2013) C Jiménez et al. LEUKEMIA
- Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors
- (2013) Marzia Varettoni et al. LEUKEMIA & LYMPHOMA
- IgBLAST: an immunoglobulin variable domain sequence analysis tool
- (2013) Jian Ye et al. NUCLEIC ACIDS RESEARCH
- Progression in smoldering Waldenstrom macroglobulinemia: long-term results
- (2012) R. A. Kyle et al. BLOOD
- Differential Diagnosis of IgM MGUS and WM According to B-Lymphoid Infiltration by Morphology and Flow Cytometry
- (2012) Enrique M. Ocio et al. Clinical Lymphoma Myeloma & Leukemia
- MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
- (2011) Jürgen Cox et al. JOURNAL OF PROTEOME RESEARCH
- IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia
- (2010) Steven R. Schuster et al. AMERICAN JOURNAL OF HEMATOLOGY
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor- B Signaling Pathways in Waldenstrom's Macroglobulinemia
- (2009) E. Braggio et al. CANCER RESEARCH
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now